These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11555152)

  • 1. Loss of heterozygosity: a potential tool in management of oral premalignant lesions?
    Zhang L; Rosin MP
    J Oral Pathol Med; 2001 Oct; 30(9):513-20. PubMed ID: 11555152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the diagnosis of oral premalignant and malignant lesions.
    Epstein JB; Zhang L; Rosin M
    J Can Dent Assoc; 2002 Nov; 68(10):617-21. PubMed ID: 12410942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Exploration of tumor suppressors p16INK4a and p14ARF in oral leukoplakias].
    Nitsche M; Koy S; Mörz M; Koch R; Eckelt U
    Mund Kiefer Gesichtschir; 2007 Dec; 11(6):317-26. PubMed ID: 17990010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can molecular assessment improve classification of head and neck premalignancy?
    Mao L
    Clin Cancer Res; 2000 Feb; 6(2):321-2. PubMed ID: 10690505
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased allelic loss in toluidine blue-positive oral premalignant lesions.
    Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites.
    Rosin MP; Lam WL; Poh C; Le ND; Li RJ; Zeng T; Priddy R; Zhang L
    Cancer Res; 2002 Nov; 62(22):6447-50. PubMed ID: 12438233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection.
    Zhang L; Poh CF; Lam WL; Epstein JB; Cheng X; Zhang X; Priddy R; Lovas J; Le ND; Rosin MP
    Oral Oncol; 2001 Sep; 37(6):505-12. PubMed ID: 11435177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer.
    Partridge M; Emilion G; Pateromichelakis S; A'Hern R; Phillips E; Langdon J
    Oral Oncol; 1998 Mar; 34(2):77-83. PubMed ID: 9682768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity at APC and MCC genes of oral cancer and leukoplakia tissues from Indian tobacco chewers.
    Sikdar N; Paul RR; Panda CK; Banerjee SK; Roy B
    J Oral Pathol Med; 2003 Sep; 32(8):450-4. PubMed ID: 12901725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulative increase of loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity.
    Jiang WW; Fujii H; Shirai T; Mega H; Takagi M
    Cancer; 2001 Nov; 92(9):2349-56. PubMed ID: 11745290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome instability predicts the progression of premalignant oral lesions.
    Siebers TJ; Bergshoeff VE; Otte-Höller I; Kremer B; Speel EJ; van der Laak JA; Merkx MA; Slootweg PJ
    Oral Oncol; 2013 Dec; 49(12):1121-8. PubMed ID: 24075955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Abnormalities in Oral Leukoplakia and Oral Cancer Progression.
    Kil TJ; Kim HS; Kim HJ; Nam W; Cha IH
    Asian Pac J Cancer Prev; 2016; 17(6):3001-6. PubMed ID: 27356725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesions.
    Guillaud M; Zhang L; Poh C; Rosin MP; MacAulay C
    Cancer Res; 2008 May; 68(9):3099-107. PubMed ID: 18451134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent allelic loss of 21q11.1 approximately q21.1 region in advanced stage oral squamous cell carcinoma.
    Chen L; Wong MP; Cheung LK; Samaranayake LP; Baum L; Samman N
    Cancer Genet Cytogenet; 2005 May; 159(1):37-43. PubMed ID: 15860355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which putatively pre-malignant oral lesions become oral cancers? Clinical relevance of early targeting of high-risk individuals.
    Sudbø J; Reith A
    J Oral Pathol Med; 2003 Feb; 32(2):63-70. PubMed ID: 12542827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral cancer genesis and progression: DNA near-diploid aneuploidization and endoreduplication by high resolution flow cytometry.
    Donadini A; Maffei M; Cavallero A; Pentenero M; Malacarne D; Di Nallo E; Truini M; Navone R; Mereu P; Scala M; Santelli A; Gandolfo S; Giaretti W
    Cell Oncol; 2010; 32(5-6):373-83. PubMed ID: 20448331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between histopathological features of dysplasia in oral leukoplakia and loss of heterozygosity.
    Fonseca-Silva T; Diniz MG; de Sousa SF; Gomez RS; Gomes CC
    Histopathology; 2016 Feb; 68(3):456-60. PubMed ID: 26042642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx.
    Tabor MP; Braakhuis BJ; van der Wal JE; van Diest PJ; Leemans CR; Brakenhoff RH; Kummer JA
    J Pathol; 2003 Mar; 199(3):354-60. PubMed ID: 12579537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.